Zhi-Hui Zhu | Cardiovascular Researches | Innovative Research Award

Published on by Cardiology and Cardiovascular Medicine

Innovative Research Award

Zhi-Hui Zhu
Zhejiang University, China
Zhi-Hui Zhu
Affiliation Zhejiang University
Country China
Scopus ID 57199280440
Documents 4
Citations 73
h-index 3
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine

The Innovative Research Award recognizes scholarly achievements that have contributed to the advancement of biomedical and life science research. Zhi-Hui Zhu of Zhejiang University has developed a research profile characterized by investigations into liver development, regenerative biology, molecular genetics, and experimental disease modeling. Through studies employing zebrafish and mammalian systems, Zhu has contributed to understanding developmental regulation, tissue regeneration, and cellular lineage mechanisms relevant to human health and disease.[1] The body of work demonstrates interdisciplinary integration of genetics, developmental biology, and translational biomedical research, providing a foundation for future applications in regenerative medicine and cardiovascular-related biological investigations.[2]

Abstract

This article summarizes the scientific contributions of Zhi-Hui Zhu in developmental biology and regenerative research. The documented publications explore liver organogenesis, gene regulation, tissue regeneration, and transgenic model development. Collectively, these studies have contributed to understanding molecular pathways that govern organ formation and repair, providing insights applicable to broader biomedical and cardiovascular research contexts.[3]

Keywords

Developmental biology; Regenerative medicine; Zebrafish genetics; Liver development; Molecular signaling; Tissue regeneration; Functional genomics; Biomedical research.

Introduction

Modern biomedical research increasingly relies on model organisms to uncover mechanisms underlying organ development and disease progression. Zhu’s investigations have focused on genetic and cellular pathways involved in liver biology, utilizing zebrafish and mammalian systems to evaluate developmental processes and regenerative responses. These studies provide mechanistic evidence supporting the role of specific genes and signaling networks in maintaining tissue integrity and recovery following injury.[1][3]

Research Profile

Affiliated with Zhejiang University, Zhi-Hui Zhu has authored and co-authored peer-reviewed publications indexed in major scientific databases. The available metrics indicate four indexed documents, seventy-three citations, and an h-index of three. Research themes encompass developmental genetics, liver biology, transgenic technologies, and regenerative mechanisms, reflecting a consistent commitment to experimentally driven biological inquiry.[1]

Research Contributions

Among Zhu’s notable contributions is the characterization of liver-enriched gene family members essential for normal liver development in zebrafish, expanding knowledge of organogenesis and developmental regulation.[2] Additional investigations examined expression patterns of homologous genes in mammalian systems, providing comparative biological insights.[3] Research on Def haploinsufficiency demonstrated activation of p53-dependent TGFβ signaling during regenerative responses, revealing mechanisms associated with scar formation following partial hepatectomy.[4] Zhu also contributed to transgenic zebrafish methodologies supporting functional genomic analysis of candidate genes involved in tumor pathogenesis.[5]

Publications

  • Chang CQ et al. (2011). Liver-enriched gene 1a and 1b encode novel secretory proteins essential for normal liver development in zebrafish.
  • Zhu ZH et al. (2012). Analysis of expression pattern of zebrafish leg1 homologous gene mu-leg1 in mouse.
  • Zhu ZH et al. (2014). Haploinsufficiency of Def activates p53-dependent TGFβ signalling and causes scar formation after partial hepatectomy.
  • Ung CY et al. (2015). Mosaic zebrafish transgenesis for functional genomic analysis of cooperative genes in tumor pathogenesis.
  • Gao C et al. (2018). Hepatocytes in a normal adult liver are derived solely from embryonic hepatocytes.

Research Impact

The research portfolio has contributed valuable evidence regarding developmental pathways, tissue regeneration, and cellular lineage tracing. These findings support broader scientific efforts aimed at understanding disease mechanisms and regenerative therapies. The citation record further indicates continued scholarly engagement with the published findings, particularly in developmental and translational biology disciplines.[1][6]

Award Suitability

Zhu’s record demonstrates sustained contributions to biological research through original investigations, methodological development, and collaborative scientific output. The integration of developmental genetics and regenerative biology aligns with the objectives of the International Research Awards on Cardiology & Cardiovascular Medicine, particularly where fundamental biological discoveries inform future therapeutic and translational applications.[5]

Conclusion

Zhi-Hui Zhu’s scholarly contributions reflect a focused research trajectory in developmental and regenerative biology. Through investigations involving gene regulation, organ development, and cellular regeneration, the researcher has advanced scientific understanding of biological processes relevant to health and disease. The documented body of work provides a credible basis for recognition through an academic research award program.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Zhi-Hui Zhu, Author ID 57199280440. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57199280440
  2. Chang CQ, Hu MJ, Zhu ZH, et al. (2011). Liver-enriched gene 1a and 1b Encode Novel Secretory Proteins Essential for Normal Liver Development in Zebrafish. PLoS ONE.
    https://doi.org/10.1371/journal.pone.0022910
  3. Zhu ZH, Hu MJ, Chang CQ, Peng JR. (2012). Analysis of expression pattern of zebrafish leg1 homologous gene mu-leg1 in mouse. Hereditas.
  4. Zhu ZH, Chen J, Xiong JW, Peng JR. (2014). Haploinsufficiency of Def Activates p53-Dependent TGFβ Signalling and Causes Scar Formation after Partial Hepatectomy. PLoS ONE.
    https://doi.org/10.1371/journal.pone.0096576
  5. Ung CY, Guo F, Zhang X, Zhu Z, Zhu S. (2015). Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis. Journal of Visualized Experiments.
    https://doi.org/10.3791/52567
  6. Gao C, Zhu Z, Gao Y, et al. (2018). Hepatocytes in a Normal Adult Liver Are Derived Solely from the Embryonic Hepatocytes. Journal of Genetics and Genomics.
    https://doi.org/10.1016/j.jgg.2017.12.003

Ersilia Nigro | Cardiovascular Researches | Innovative Research Award

Published on by Cardiology and Cardiovascular Medicine

Innovative Research Award

Ersilia Nigro
Università della Campania Vanvitelli, Italy

Ersilia Nigro
Affiliation Università della Campania Vanvitelli
Country Italy
Scopus ID 57194323816
Documents 119
Citations 3,964
h-index 33
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-5637-1685

The Innovative Research Award recognizes the scholarly contributions of Ersilia Nigro, an Italian researcher affiliated with Università della Campania Vanvitelli, whose work has advanced knowledge in cardiovascular and metabolic sciences. Her interdisciplinary research explores adipokines, inflammatory biomarkers, exercise physiology, metabolic dysfunction, and lifestyle-related determinants of cardiovascular health. With an established publication record, a Scopus h-index of 33, and nearly four thousand citations, her investigations have contributed to translational approaches linking molecular mechanisms with clinical practice.[1]

Abstract

This article summarizes the scientific profile of Ersilia Nigro in relation to the Innovative Research Award. Her work integrates molecular cardiology, metabolism, and preventive medicine, emphasizing biomarkers associated with obesity, inflammation, exercise adaptation, and cardiovascular risk. Current research demonstrates sustained engagement with emerging topics including adiponectin signaling, orexin regulation, muscle wasting, and cardiometabolic interventions.[2]

Keywords

Cardiovascular research; adipokines; exercise physiology; obesity; inflammation; cardiometabolic health; translational medicine; biomarkers.

Introduction

Contemporary cardiovascular science increasingly relies on multidisciplinary investigations connecting lifestyle behaviors with molecular pathways. Nigro’s research addresses this need by examining how exercise, nutrition, sleep, and metabolic dysfunction influence cardiovascular outcomes and chronic disease progression.[3]

Research Profile

Her publication portfolio spans clinical, translational, and experimental studies. Indexed in Scopus with 119 documents and 3,964 citations, her scholarship demonstrates sustained influence across cardiovascular medicine, endocrinology, and metabolic research. Collaborative investigations frequently examine biomarker-driven approaches to patient stratification and disease management.[1]

Research Contributions

  • Investigation of adiponectin isoforms and inflammatory biomarkers in chronic diseases.
  • Evaluation of exercise interventions and their effects on cardiometabolic health.
  • Analysis of lifestyle factors, including sleep and nutrition, in cardiovascular regulation.
  • Research on muscle wasting, dyslipidemia, and patient management strategies in chronic respiratory disorders.

Publications

Recent publications include studies on irisin responses in obese middle-aged males, exercise-induced modulation of adiponectin, orexin and lifestyle habits, COPD-associated muscle wasting, and inflammatory markers in Crohn’s disease.[4]

Research Impact

The impact of Nigro’s work is reflected in extensive citation activity and the adoption of biomarker-based approaches within cardiometabolic research. Her studies support evidence-informed strategies for prevention, risk assessment, and personalized interventions targeting obesity-related cardiovascular conditions.[5]

Award Suitability

The Innovative Research Award acknowledges scientific originality, interdisciplinary collaboration, and measurable influence. Nigro’s sustained contributions across cardiovascular medicine, molecular biology, and preventive health align with these criteria through a record of peer-reviewed outputs, translational relevance, and international visibility.[6]

Conclusion

Ersilia Nigro has established a significant research profile at the intersection of cardiovascular science and metabolism. Her investigations continue to inform understanding of biomolecular pathways underlying cardiometabolic disorders while advancing preventive and therapeutic perspectives relevant to contemporary healthcare challenges.

References

  1. Elsevier. (n.d.). Scopus author details: Ersilia Nigro, Author ID 57194323816. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57194323816
  2. Nigro, E., et al. (2026). Effects of Two Different Training Programs on Cardiometabolic Health, Body Composition and Irisin in Middle Age Obese Males: A Pilot Study. Life.
    DOI: https://doi.org/10.3390/life16040657
  3. Nigro, E., et al. (2025). Orexin and Lifestyle Habits: A Meaningful Connection Among Nutrition, Physical Activity, and Sleep Pattern in Health and Diseases. International Journal of Molecular Sciences.
    DOI: https://doi.org/10.3390/ijms26188980
  4. Nigro, E., et al. (2026). Acute Resistance Exercise Temporarily Reduces Circulating Adiponectin in Trained Young Men: A Pilot Study. Biomolecules. DOI: https://doi.org/10.3390/biom16020229
  5. Nigro, E., et al. (2025). Muscle Wasting and Treatment of Dyslipidemia in COPD: Implications for Patient Management. Biomedicines.
    DOI: https://doi.org/10.3390/biomedicines13081817
  6. Nigro, E., et al. (2025). Adiponectin and HMW Oligomers in Relation to Inflammatory Markers in Crohn’s Disease Patients. Biomedicines.
    DOI: https://doi.org/10.3390/biomedicines13020273

Zhuofeng Lin | Myocardial infarction | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Zhuofeng Lin | Myocardial infarction | Best Researcher Award 

Prof. Dr. Zhuofeng Lin, Guangdong Medical University, China

Prof. Dr. Zhuofeng Lin is the Dean of the Experimental Animal Center and Dean of the Innovational Center of Cardiometabolic Disease at Guangdong Medical University, China. His research focuses on cross-organ communication in cardiovascular and metabolic diseases, particularly the role of metabolic hormones and obesity. He has made significant contributions to understanding FGF21 metabolic regulation, impacting blood glucose stability, blood pressure control, and anti-atherosclerosis therapies. His work also explores new targets for anti-myocardial infarction, heart failure, and vascular calcification drugs, driving innovation in metabolic and cardiovascular medicine. His research is widely recognized in international medical science.

AUTHOR PROFILE

Google Scholar Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Dr. Zhuofeng Lin’s academic journey began with a strong foundation in medical sciences, focusing on cardiovascular and metabolic diseases. His early research explored physiological mechanisms and metabolic interactions, leading him to specialize in cross-organ communication and metabolic regulation. His education and initial training laid the groundwork for his extensive contributions to cardiometabolic research.

🏢PROFESSIONAL ENDEAVORS:

Prof. Lin has held prestigious positions at Guangdong Medical University, where he currently serves as:

  • Dean of the Experimental Animal Center 🐁
  • Dean of the Innovational Center of Cardiometabolic Disease 🫀

His leadership in these institutions has driven significant advancements in experimental research methodologies and the development of innovative treatment strategies for metabolic disorders.

🔍CONTRIBUTIONS AND RESEARCH FOCUS ON MYOCARDIAL INFARCTION:

Prof. Lin’s research is dedicated to practical applications, with a strong emphasis on:

  • Cross-organ communication in cardiovascular and metabolic diseases
  • Pathogenesis of cardiometabolic disorders linked to metabolic hormones and obesity
  • Fibroblast Growth Factor 21 (FGF21) and its role in metabolic regulation

His studies have provided groundbreaking insights into FGF21’s ability to regulate:
✅ Blood glucose levels
✅ Blood pressure stability
✅ Anti-atherosclerosis mechanisms
✅ Anti-Metabolic Dysfunction-Associated Steatohepatitis (MASH) therapies

Additionally, his work focuses on discovering new therapeutic targets for:
⚕️ Anti-myocardial infarction drugs
⚕️ Anti-heart failure treatments
⚕️ Anti-vascular calcification solutions

🌍IMPACT AND INFLUENCE:

Prof. Lin’s research has had a profound impact on global medical science, particularly in the fields of:
🔹 Metabolic disease management
🔹 Cardiovascular treatment innovations
🔹 Therapeutic drug development

His studies have influenced clinical practices, contributing to better patient outcomes in cardiovascular and metabolic health. His pioneering work in hormonal regulation and metabolic stability has inspired numerous scientists and researchers worldwide.

📄ACADEMIC CITES AND RECOGNITION:

Prof. Lin’s research is widely recognized in high-impact medical journals, with numerous citations supporting his theories. His work on FGF21 metabolic regulation is frequently referenced in the fields of endocrinology, cardiology, and metabolic research. He has been a keynote speaker at international medical conferences, sharing his insights with the global scientific community.

🚀LEGACY AND FUTURE CONTRIBUTIONS:

With an unwavering commitment to scientific innovation, Prof. Lin continues to shape the future of medical research. His ongoing projects aim to:
🔬 Develop novel cardiometabolic therapies
🔬 Enhance cross-organ communication research
🔬 Introduce cutting-edge treatments for heart disease and metabolic disorders

His legacy will be defined by his transformative contributions to medicine, paving the way for future breakthroughs in cardiovascular and metabolic health.

💡CONCLUSION:

Prof. Dr. Zhuofeng Lin is a pioneering leader in cardiometabolic research, making groundbreaking contributions to understanding metabolic regulation and cardiovascular health. His work on FGF21 has revolutionized approaches to blood glucose stability, blood pressure control, and anti-atherosclerosis treatments . With a vision for therapeutic innovation, he continues to explore new drug targets for heart failure, myocardial infarction, and vascular calcification . His impact on medical science is profound, shaping the future of metabolic and cardiovascular treatments. His dedication ensures lasting advancements in healthcare and patient well-being.

TOP NOTABLE PUBLICATIONS

Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice

Authors: Z Lin, H Tian, KSL Lam, S Lin, RCL Hoo, M Konishi, N Itoh, Y Wang, …
Journal: Cell Metabolism
Year: 2013

Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice

Authors: Z Lin, X Pan, F Wu, D Ye, Y Zhang, Y Wang, L Jin, Q Lian, Y Huang, …
Journal: Circulation
Year: 2015

Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile

Authors: Z Lin, Z Wu, X Yin, Y Liu, X Yan, S Lin, J Xiao, X Wang, W Feng, X Li
Journal: PLoS One
Year: 2010

Exercise alleviates obesity-induced metabolic dysfunction via enhancing FGF21 sensitivity in adipose tissues

Authors: L Geng, B Liao, L Jin, Z Huang, CR Triggle, H Ding, J Zhang, Y Huang, …
Journal: Cell Reports
Year: 2019

Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2

Authors: D Ye, K Yang, S Zang, Z Lin, HT Chau, Y Wang, J Zhang, J Shi, A Xu, …
Journal: Journal of Hepatology
Year: 2016

Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese

Authors: Z Lin, Z Zhou, Y Liu, Q Gong, X Yan, J Xiao, X Wang, S Lin, W Feng, X Li
Journal: PLoS One
Year: 2011

FGF21 prevents angiotensin II-induced hypertension and vascular dysfunction by activation of ACE2/angiotensin-(1–7) axis in mice

Authors: X Pan, Y Shao, F Wu, Y Wang, R Xiong, J Zheng, H Tian, B Wang, …
Journal: Cell Metabolism
Year: 2018

Adiponectin protects against acetaminophen-induced mitochondrial dysfunction and acute liver injury by promoting autophagy in mice

Authors: Z Lin, F Wu, S Lin, X Pan, L Jin, T Lu, L Shi, Y Wang, A Xu, X Li
Journal: Journal of Hepatology
Year: 2014

Pancreatic fibroblast growth factor 21 protects against type 2 diabetes in mice by promoting insulin expression and secretion in a PI3K/Akt signaling‐dependent manner

Authors: Y Pan, B Wang, J Zheng, R Xiong, Z Fan, Y Ye, S Zhang, Q Li, F Gong, …
Journal: Journal of Cellular and Molecular Medicine
Year: 2019

Dynamic change of serum FGF21 levels in response to glucose challenge in human

Authors: Z Lin, Q Gong, C Wu, J Yu, T Lu, X Pan, S Lin, X Li
Journal: The Journal of Clinical Endocrinology & Metabolism
Year: 2012

Songyun Wang | Arrhythmia | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Songyun Wang | Arrhythmia | Best Researcher Award

XIngcheng Yi | Myocardial tissue repair | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

🎓Current Position:

Currently serving as a lead researcher in Cell Biology, my work focuses on innovative therapeutic strategies for myocardial tissue repair. Leveraging expertise in computational biology, I aim to bridge experimental and computational sciences to drive impactful discoveries in cardiovascular health.

📚Academic Background:

Earned a Ph.D. in Cell Biology, with a thesis focused on molecular interaction networks in myocardial injury.
Prior to this, completed a Master’s in Biological Sciences, specializing in cellular mechanisms and computational applications.

📝Publications Achievements:

Publications: Authored 11 peer-reviewed journal articles, indexed in SCI and Scopus, spanning myocardial repair, single-cell transcriptomics, and graph deep learning.
Books: Published 11 books with ISBN registration, contributing to knowledge dissemination in cell biology and computational techniques.
Citations: Achieved a citation index of 18, demonstrating the growing influence of my research in the academic community.
Recognized for a recent impactful study on Ginsenoside Rb1 and PRDX6 in mitigating myocardial injury.

🔬Ongoing Research Projects:

Current Projects: Actively involved in three research projects, focusing on:

  1. Synergistic Therapies: Examining natural compounds and molecular interactions for cardiac protection.
  2. Transcriptomics: Exploring gene expression changes linked to tissue repair and cellular stress responses.
  3. Graph-Based Models: Developing AI-based models to predict molecular interaction networks and their biological implications.

Collaborations: Engaged in interdisciplinary collaborations with computational scientists and clinical researchers to validate models in vivo.

🔍Research Interests:

Areas of expertise and passion include:

  • Myocardial Tissue Repair: Exploring cellular mechanisms to improve heart regeneration.
  • Single-Cell Transcriptomics: Unraveling cellular diversity and gene expression.
  • Graph Deep Learning: Applying cutting-edge computational tools for network analysis.
  • Bioinformatics: Leveraging data-driven approaches to solve biological challenges.

🏆Awards and Scholarships:

Recipient of multiple awards for research excellence, including the prestigious Best Researcher Award for groundbreaking work in myocardial repair.
Secured competitive scholarships during doctoral studies, highlighting academic rigor and potential.

🎤Professional Associations:

Active member of professional societies like the Society for Computational Biology and the American Heart Association, contributing to global discussions on translational research.

🎓Training & Workshops: 

Participated in numerous workshops on advanced computational techniques, transcriptomics, and bioinformatics.
Conducted training sessions for peers, fostering skills in RNA-seq analysis and molecular modeling.

🧪Laboratory Experience and Publications: 

Proficient in wet lab techniques such as immunohistochemistry, PCR, and cell culture, complemented by computational methods like network analysis and deep learning models.
Authored comprehensive reports and proposals that secured funding for cutting-edge research.

🛠️Tasks Completed as a Researcher:

Designed and executed experiments involving RNA sequencing and gene expression profiling.
Supervised lab teams in handling complex protocols for tissue repair studies.
Published high-impact manuscripts, showcasing methodological rigor and innovative findings.

🎤Oral Presentations:

Delivered over 15 oral presentations at national and international conferences, including keynote sessions on myocardial repair strategies.
Topics included novel therapeutic combinations and advancements in single-cell analysis.

🌟Success Factors:

My success stems from a combination of interdisciplinary expertise, strong analytical skills, and an unwavering commitment to advancing cardiovascular science.
Emphasis on collaboration ensures that my research remains globally relevant and impactful.

🌍Conclusion: 

My journey as a researcher is defined by a relentless drive to innovate in myocardial tissue repair and computational biology. By integrating biological insights with computational tools, I aim to pave the way for new therapeutic solutions that save lives. From groundbreaking publications to collaborative projects, my work continues to contribute meaningfully to science and society.

Top Notable Publications:

Article: Hypoxia adaptation mechanism in rats’ peripheral auditory system in high altitude migration: a time series transcriptome analysis
Authors: Wang, L., Yi, X., Zhou, Y., Su, X., Wang, P.
Year: 2024
Journal: Scientific Reports
Citations: 0

Letter: Individualized dynamic frailty-tailored therapy (DynaFiT) in elderly patients with newly diagnosed multiple myeloma: a prospective study
Authors: Zhang, Y., Liang, X., Xu, W., Dai, Y., Jin, F.
Year: 2024
Journal: Journal of Hematology and Oncology
Citations: 1

Article: Dynamics of minimal residual disease and its clinical implications in multiple myeloma: A retrospective real-life analysis
Authors: Xu, W., Liang, X., Liu, S., Dai, Y., Jin, F.
Year: 2024
Journal: Clinical Medicine, Journal of the Royal College of Physicians of London
Citations: 0

Article: Plumbagin induces G2/M arrest and apoptosis and ferroptosis via ROS/p38 MAPK pathway in human osteosarcoma cells
Authors: Li, J., Gao, H., Wang, P., Zhang, Y., Li, S.
Year: 2024
Journal: Alexandria Engineering Journal
Citations: 1

Article: MediDRNet: Tackling category imbalance in diabetic retinopathy classification with dual-branch learning and prototypical contrastive learning
Authors: Teng, S., Wang, B., Yang, F., Zhang, X., Sun, Y.
Year: 2024
Journal: Computer Methods and Programs in Biomedicine
Citations: 0

Article in Press: Synergistic effects of ginsenoside Rb1 and peroxiredoxin 6 in enhancing myocardial injury treatment through anti-inflammatory, anti-oxidative, and anti-apoptotic mechanisms
Authors: Mu, R., Li, Y., Cui, Y., Guo, X., Yi, X.
Year: 2024
Journal: Journal of Ginseng Research
Citations: 0

Letter: More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma
Authors: Tian, M., Liang, X., Xu, W., Dai, Y., Jin, F.
Year: 2023
Journal: Annals of Hematology
Citations: 0

Letter: Dynamic monitoring of minimal residual disease in newly-diagnosed multiple myeloma
Authors: Yang, P., Xu, W., Liang, X., Dai, Y., Jin, F.
Year: 2023
Journal: American Journal of Hematology
Citations: 3

Article: Proposed risk-scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma
Authors: Yang, P., Chen, H., Liang, X., Dai, Y., Jin, F.
Year: 2023
Journal: American Journal of Hematology
Citations: 7

Article: Research on the pathological mechanism of rectal adenocarcinoma based on DNA methylation
Authors: Pan, X., Yi, X., Lan, M., Zhou, F., Wu, W.
Year: 2023
Journal: Medicine (United States)
Citations: 2